archive
opioids

Should Purdue Pharma Profit From Opioid Antidotes?

Purdue Pharma has been accused of helping cause the opioid epidemic, including in a new Colorado case. Now the firm’s former chairman, Richard Sackler, is being criticized for patenting an opioid that eases withdrawal symptoms.

archive archive archive
opioids

One Opioid Crisis Or Many?

A major thread in public policy discussions is an asserted need to “solve” the opioid crisis by limiting production of opioid analgesics and reducing medical exposure to potentially addicting drugs. But are such steps actually a remedy?  A pain specialist argues they aren’t.

archive
addiction

Should Opioid Addicts Be Forced to Undergo Medical Treatment?

According to a forthcoming study in the Journal of Law, Medicine, and Ethics, there’s little evidence that opioid addicts benefit from involuntary commitment, and the “legal and ethical” concerns raised by such strategies should make policymakers think twice about employing them.

archive

Trump Opioid Plan Includes a Windfall for Vivitrol

The White House’s national strategy to combat the opioid crisis, unveiled last week, would expand a particular kind of addiction treatment in federal criminal justice settings: a single drug, manufactured by a single company, with mixed views on the evidence regarding its use. The drug is Vivitrol, manufactured by Alkermes, a Massachusetts pharmaceutical company.

archive archive archive archive